证券记录 · 已归档季度
VTRS
Viatris Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
21被追踪持有人
+3Δ持有人
124.36M持有股份
$1.44B报告持仓市值
+3新建仓位
−0清仓
动量输入（同类管理人）：
持有人广度 +16.7% ·
股份流向 +2.2% ·
净新建仓位 +14.3%
· 公式
广泛增持：持股数量上升，持有人数量增加
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 10.99M | $194.70M | n/a | −2 |
| Q2 2026 | 148 | -1 | 754.00M | $11.97B | +6 | −8 |
| Q1 2026 | 153 | +6 | 683.49M | $9.23B | +9 | −4 |
| Q4 2025 | 146 | -3 | 743.40M | $9.25B | +1 | −3 |
| Q3 2025 | 22 | -3 | 488.65M | $4.84B | n/a | −4 |
| Q2 2025 | 23 | +2 | 455.87M | $4.07B | +3 | −1 |
| Q1 2025 | 18 | -1 | 210.93M | $1.84B | +1 | −2 |
| Q4 2024 | 19 | -3 | 200.96M | $2.50B | +1 | −4 |
| Q3 2024 | 21 | +3 | 124.36M | $1.44B | +3 | n/a |
| Q2 2024 | 18 | n/a | 121.66M | $1.29B | n/a | n/a |
持有人 · Q3 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 48.79M | -14.2% | $566.40M | 0.1% | ▼ Trim | 2 | SEC ↗ ×2 |
| 2 | Geode Capital Management ✦ (被动) | 29.44M | +1.5% | $340.64M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 3 | Norges Bank ✦ (被动) | 11.08M | -12.4% | $128.60M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | Glenview Capital ✦ | 7.57M | +16.6% | $87.91M | 1.9% | ▲ Add | 2 | SEC ↗ |
| 5 | Greenlight Capital (DME Capital) ✦ | 7.27M | -1.8% | $84.41M | 3.5% | ▼ Trim | 2 | SEC ↗ ×2 |
| 6 | Millennium Management ✦ | 6.15M | +719.0% | $71.43M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 4.22M | +2298.4% | $49.03M | 0.1% | ▲ Add | 2 | SEC ↗ ×2 |
| 8 | Arrowstreet Capital ✦ | 2.57M | +155.9% | $29.83M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 2.17M | -29.9% | $25.23M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 10 | Bridgewater Associates ✦ | 1.34M | +253.4% | $15.54M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 11 | Gotham Asset Management ✦ | 1.33M | +36.3% | $15.40M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 12 | D. E. Shaw & Co. ✦ | 771.99K | -16.5% | $8.96M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | Two Sigma Investments ✦ | 501.54K | +208.1% | $5.82M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | GAMCO Investors ✦ | 314.12K | -3.7% | $3.65M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | Renaissance Technologies ✦ | 301.32K | 新增 | $3.50M | 0.0% | New | 1 | SEC ↗ |
| 16 | Point72 Asset Management ✦ | 299.71K | 新增 | $3.48M | 0.0% | New | 1 | SEC ↗ |
| 17 | Capital World Investors ✦ | 110.68K | 0.0% | $1.28M | 0.0% | Held | 2 | SEC ↗ |
| 18 | Wellington Management ✦ | 61.87K | -20.2% | $718,357 | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 19 | Marshall Wace ✦ | 51.62K | -95.3% | $599,273 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | Fisher Asset Management ✦ | 12.59K | -94.2% | $146,170 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 21 | Soros Fund Management ✦ | 10.23K | 新增 | $118,828 | 0.0% | New | 1 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Renaissance Technologies | $3.50M | 0.0% |
| Point72 Asset Management | $3.48M | 0.0% |
| Soros Fund Management | $118,828 | 0.0% |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1,011 持有人, 984.50M 股份, $12.02B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
Sep 08
SC 13G/A: FMR LLC
Aug 12
SC 13G/A: DAVIS SELECTED ADVISERS
Aug 06
SC 13G: FMR LLC
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2024 ·
方法论 ·
通过API获取此数据